Developing a risk score for early detection of bowel cancer using routine blood test data
<p><strong>Introduction</strong></p> <p>Bowel cancer is the fourth most common type of cancer in the UK. Approximately 55% of patients are diagnosed with a late-stage tumour (Stage 3 and 4), where likelihood of survival is reduced: five-year survival is 93% at Stage 1 v...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
2021
|
| Aiheet: |